PRDM1/BLIMP1: A tumor suppressor gene in B and T cell lymphomas

Leukemia and Lymphoma

Volumn 56, Issue 5, 2015, Pages 1223-1228

  Boi, Michela ^a,b   Zucca, Emanuele ^c   Inghirami, Giorgio ^a,b,d   Bertoni, Francesco ^c,e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^d UNIVERSITY OF TURIN   (Italy)

^e INSTITUTE OF ONCOLOGY RESEARCH   (Switzerland)

Author keywords

ALCL; BCL6; BLIMP1; DLBCL; NK; PAX5; PRDM1

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; PRDM1 PROTEIN, HUMAN; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CHROMOSOME 6Q; FETUS DEVELOPMENT; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE STRUCTURE; HISTONE METHYLATION; HUMAN; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE; REVIEW; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE; ZINC FINGER MOTIF; ANIMAL; CELL TRANSFORMATION; CHEMISTRY; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; REPRESSOR PROTEINS; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEINS;

EID: 84932176870     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.953155     Document Type: Review

References (36)

1. Keller AD, Maniatis T. Identif cation and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 1991; 5:868-879.
2. Turner CA Jr, Mack DH, Davis MM. Blimp-1, a novel zinc f nger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994; 77: 297-306.
3. Huang S. Blimp-1 is the murine homolog of the human transcriptional repressor PRDI-BF1. Cell 1994;78:9.
4. Martins G, Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008;26:133-169.
5. Mock BA, Liu L, LePaslier D, et al. The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10. Genomics 1996;37:24-28.
6. Gyory I, Fejer G, Ghosh N, et al. Identif cation of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol 2003;170:3125-3133.
7. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, et al. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 2003;19:607-620.
8. Keller AD, Maniatis T. Only two of the f ve zinc f ngers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specif c DNA binding. Mol Cell Biol 1992; 12: 1940-1949.
9. Kuo TC, Calame KL. B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. J Immunol 2004; 173: 5556-5563.
10. Ren B, Chee KJ, Kim TH, et al. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 1999;13:125-137.
11. Yu J, Angelin-Duclos C, Greenwood J, et al. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol 2000;20:2592-2603.
12. Vincent SD, Dunn NR, Sciammas R, et al. The zinc f nger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specif cation of primordial germ cells in the mouse. Development 2005; 132: 1315-1325.
13. Kallies A, Hawkins ED, Belz GT, et al. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 2006;7:466-474.
14. Chang DH, Cattoretti G, Calame KL. The dynamic expression pattern of B lymphocyte induced maturation protein-1 (Blimp-1) during mouse embryonic development. Mech Dev 2002; 117: 305-309.
15. Kallies A, Hasbold J, Tarlinton DM, et al. Plasma cell ontogeny def ned by quantitative changes in blimp-1 expression. J Exp Med 2004;200:967-977.
16. Messika EJ, Lu PS, Sung YJ, et al. Dif erential Effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J Exp Med 1998; 188: 515-525.
17. Chang DH, Angelin-Duclos C, Calame K. BLIMP-1: trigger for diferentiation of myeloid lineage. Nat Immunol 2000;1:169-176.
18. Nishikawa K, Nakashima T, Hayashi M, et al. Blimp1-mediated repression of negative regulators is required for osteoclast diferentiation. Proc Natl Acad Sci USA 2010;107:3117-3122.
19. Chan YH, Chiang MF, Tsai YC, et al. Absence of the transcriptional repressor Blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J Immunol 2009; 183: 7039-7046.
20. Martins GA, Cimmino L, Shapiro-Shelef M, et al. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 2006;7:457-465.
21. Fairfax KA, Kallies A, Nutt SL, et al. Plasma cell development: from B-cell subsets to long-term survival niches. Semin Immunol 2008;20:49-58.
22. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8: 22-33.
23. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005;5:230-242.
24. Fearon DT, Manders P, Wagner SD. Arrested dif erentiation, the self-renewing memory lymphocyte, and vaccination. Science 2001;293:248-250.
25. Klein U, Casola S, Cattoretti G, et al. Transcription factor IRF4 controls plasma cell dif erentiation and class-switch recombination. Nat Immunol 2006;7:773-782.
26. Sciammas R, Shafer AL, Schatz JH, et al. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell diferentiation. Immunity 2006;25:225-236.
27. Kallies A, Nutt SL. Terminal dif erentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol 2007; 19: 156-162.
28. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009;31:401-411.
29. Kusam S, Toney LM, Sato H, et al. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J Immunol 2003; 170:2435-2441.
30. Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/BLIMP1 gene in dif use large B cell lymphoma. J Exp Med 2006;203:311-317.
31. Tam W, Gomez M, Chadburn A, et al. Mutational analysis of PRDM1 indicates a tumor-suppressor role in dif use large B-cell lymphomas. Blood 2006; 107: 4090-4100.
32. Mandelbaum J, Bhagat G, Tang H, et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like dif use large B cell lymphoma. Cancer Cell 2010; 18: 568-579.
33. Calado DP, Zhang B, Srinivasan L, et al. Constitutive canonical NF-kappaB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like dif use large cell lymphoma. Cancer Cell 2010;18:580-589.
34. Karube K, Nakagawa M, Tsuzuki S, et al. Identif cation of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011;118:3195-3204.
35. Kucuk C, Iqbal J, Hu X, et al. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci USA 2011; 108:20119-20124.
36. Boi M, Rinaldi A, Kwee I, et al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood 2013; 122: 2683-2693.